- 2012 Publications
- 2011 Publications
- 2010 Publications
- 2009 Publications
- 2008 Publications
- 2007 Publications
- 2006 Publications
- 2005 Publications
- 2004 Publications
- 2003 Publications
- 2002 Publications
- 2001 Publications
- 2000 Publications
- 1999 Publications
- 1998 Publications
- »1997 Publications
- SoleCRIS-Current Research Information System
IBT Publications 1997
NOTE: This list is not exhaustive because it has been collected by an automatic procedure from PubMed. It may also contain publications not related to IMT or Regea authors (authors having the same name). The same publication may also appear more than once in case several research groups have participated in the writing. |
| Lamminmaki U, Villoutreix BO, Jauria P, Saviranta P, Vihinen M, Nilsson L, Teleman O, Lovgren T Structural analysis of an anti-estradiol antibody. Mol Immunol ;34(16-17)1215-26 PMID |
| Vihinen M, Nore BF, Mattsson PT, Backesjo CM, Nars M, Koutaniemi S, Watanabe C, Lester T, Jones A, Ochs HD, Smith CI Missense mutations affecting a conserved cysteine pair in the TH domain of Btk. FEBS Lett 1997 ;413(2)205-10 PMID |
| Saha BK, Curtis SK, Vogler LB, Vihinen M Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia. Mol Med 1997 ;3(7)477-85 PMID |
| Joukov V, Vihinen M, Vainikka S, Sowadski JM, Alitalo K, Bergman M Identification of csk tyrosine phosphorylation sites and a tyrosine residue important for kinase domain structure. Biochem J 1997 ;322 ( Pt 3)927-35 PMID |
| Lappalainen I, Ollila J, Smith CI, Vihinen M Registries of immunodeficiency patients and mutations. Hum Mutat 1997 ;10(4)261-7 PMID |
| Vihinen M, Mattsson PT, Smith CI BTK, the tyrosine kinase affected in X-linked agammaglobulinemia. Front Biosci 1997 ;2d27-42 PMID |
| Vihinen M, Belohradsky BH, Haire RN, Holinski-Feder E, Kwan SP, Lappalainen I, Lehvaslaiho H, Lester T, Meindl A, Ochs HD, Ollila J, Vorechovsky I, Weiss M, Smith CI BTKbase, mutation database for X-linked agammaglobulinemia (XLA) Nucleic Acids Res 1997 ;25(1)166-71 PMID |
| Sallinen SL, Sallinen P, Haapasalo H, Kononen J, Karhu R, Helén P, Isola J Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas. Am J Pathol 1997 ;151(6)1799-807 PMID |
| Holli K, Isola J, Cuzick J Hormone replacement therapy and biological aggressiveness of breast cancer. Lancet 1997 ;350(9092)1704-5 PMID |
| Koivisto P, Visakorpi T, Rantala I, Isola J Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer. J Pathol 1997 ;183(1)51-6 PMID |
| Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, Waldman FM Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997 ;74(5)513-7 PMID |
| Krohn K, Ovod V, Vilja P, Heino M, Scott H, Kyriakou DS, Antonarakis S, Jacobs HT, Isola J, Peterson P Immunochemical characterization of a novel mitochondrially located protein encoded by a nuclear gene within the DFNB8/10 critical region on 21q22.3. Biochem Biophys Res Commun 1997 ;238(3)806-10 PMID |
| Karhu R, Siitonen S, Tanner M, Keinänen M, Mäkipernaa A, Lehtinen M, Vilpo JA, Isola J Genetic aberrations in pediatric acute lymphoblastic leukemia by comparative genomic hybridization. Cancer Genet Cytogenet 1997 ;95(2)123-9 PMID |
| Kuukasjärvi T, Karhu R, Tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997 ;57(8)1597-604 PMID |
| Raitanen MP, Tammela TL, Kallioinen M, Isola J P53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer. J Urol 1997 ;157(4)1250-3 PMID |
| Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, Tanner M, Isola J, Barkardottir RB, Borg A, Kallioniemi OP Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 1997 ;57(7)1222-7 PMID |
| Kuukasjärvi T, Tanner M, Pennanen S, Karhu R, Kallioniemi OP, Isola J Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Am J Pathol 1997 ;150(4)1465-71 PMID |
| Holli K, Isola J Effect of age on the survival of breast cancer patients. Eur J Cancer 1997 ;33(3)425-8 PMID |
| Kuukasjärvi T, Tanner M, Pennanen S, Karhu R, Visakorpi T, Isola J Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes Cancer 1997 ;18(2)94-101 PMID |
| Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi OP Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 1997 ;57(2)314-9 PMID |
| Palmberg C, Koivisto P, Hyytinen E, Isola J, Visakorpi T, Kallioniemi OP, Tammela T Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade. Eur Urol 1997 ;31(2)216-9 PMID |
| Jacobs HT Mitochondrial deafness. Ann Med 1997 ;29(6)483-91 PMID |
| Shah ZH, O'Dell KM, Miller SC, An X, Jacobs HT Metazoan nuclear genes for mitoribosomal protein S12. Gene 1997 ;204(1-2)55-62 PMID |
| Krohn K, Ovod V, Vilja P, Heino M, Scott H, Kyriakou DS, Antonarakis S, Jacobs HT, Isola J, Peterson P Immunochemical characterization of a novel mitochondrially located protein encoded by a nuclear gene within the DFNB8/10 critical region on 21q22.3. Biochem Biophys Res Commun 1997 ;238(3)806-10 PMID |
| Holt IJ, Dunbar DR, Jacobs HT Behaviour of a population of partially duplicated mitochondrial DNA molecules in cell culture: segregation, maintenance and recombination dependent upon nuclear background. Hum Mol Genet 1997 ;6(8)1251-60 PMID |
| Ali ST, Coggins JR, Jacobs HT The study of cell-death proteins in the outer mitochondrial membrane by chemical cross-linking. Biochem J 1997 ;325 ( Pt 2)321-4 PMID |
| Reid FM, Rovio A, Holt IJ, Jacobs HT Molecular phenotype of a human lymphoblastoid cell-line homoplasmic for the np 7445 deafness-associated mitochondrial mutation. Hum Mol Genet 1997 ;6(3)443-9 PMID |
| Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjakoski K, Pyrhonen S, Kallioniemi OP, Muhonen T, Luce M, Frank TS, Nevanlinna H Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet 1997 ;6(13)2309-15 PMID |
| Mahlamaki EH, Hoglund M, Gorunova L, Karhu R, Dawiskiba S, Andren-Sandberg A, Kallioniemi OP, Johansson B Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 1997 ;20(4)383-91 PMID |
| Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP Genome screening by comparative genomic hybridization. Trends Genet 1997 ;13(10)405-9 PMID |
| Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997 ;277(5328)965-8 PMID |
| Karhu R, Knuutila S, Kallioniemi OP, Siltonen S, Aine R, Vilpo L, Vilpo J Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL Group. Genes Chromosomes Cancer 1997 ;19(4)286-90 PMID |
| Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997 ;57(8)1597-604 PMID |
| Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, Tanner M, Isola J, Barkardottir RB, Borg A, Kallioniemi OP Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 1997 ;57(7)1222-7 PMID |
| Kuukasjarvi T, Tanner M, Pennanen S, Karhu R, Kallioniemi OP, Isola J Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Am J Pathol 1997 ;150(4)1465-71 PMID |
| Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi OP Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 1997 ;57(2)314-9 PMID |
| Matikainen M, Schleutker J, Visakorpi T, Kallioniemi OP [ Hereditary prostate cancer with gene location] Duodecim 1997 ;113(6)461-2 PMID |
| Palmberg C, Koivisto P, Hyytinen E, Isola J, Visakorpi T, Kallioniemi OP, Tammela T Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade. Eur Urol 1997 ;31(2)216-9 PMID |
| Hyytinen ER, Thalmann GN, Zhau HE, Karhu R, Kallioniemi OP, Chung LW, Visakorpi T Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model. Br J Cancer 1997 ;75(2)190-5 PMID |
| Kallioniemi OP Linking chromosomal clues. Nat Genet 1997 ;15(1)5-6 PMID |
| Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N Positional cloning of the APECED gene. Nat Genet 1997 ;17(4)393-8 PMID |
| Eary JF, Krohn KA, Press OW, Durack L, Bernstein ID Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma. Nucl Med Biol 1997 ;24(7)635-8 PMID |
| Graham MM, Peterson LM, Link JM, Evans ML, Rasey JS, Koh WJ, Caldwell JH, Krohn KA Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies. J Nucl Med 1997 ;38(10)1631-6 PMID |
| Krohn K, Ovod V, Vilja P, Heino M, Scott H, Kyriakou DS, Antonarakis S, Jacobs HT, Isola J, Peterson P Immunochemical characterization of a novel mitochondrially located protein encoded by a nuclear gene within the DFNB8/10 critical region on 21q22.3. Biochem Biophys Res Commun 1997 ;238(3)806-10 PMID |
| Link JM, Synovec RE, Krohn KA, Caldwell JH High speed liquid chromatography of phenylethanolamines for the kinetic analysis of [11C]-meta-hydroxyephedrine and metabolites in plasma. J Chromatogr B Biomed Sci Appl 1997 ;693(1)31-41 PMID |
| Krohn K, Bahramsari R, Florke U, Ludewig K, Kliche-Spory C, Michel A, Aust HJ, Draeger S, Schulz B, Antus S Dihydroisocoumarins from fungi: isolation, structure elucidation, circular dichroism and biological activity. Phytochemistry 1997 ;45(2)313-20 PMID |
| Krohn K, Boker N, Florke U, Freund C Synthesis of Angucyclines. 8. Biomimetic-Type Synthesis of Rabelomycin, Tetrangomycin, and Related Ring B Aromatic Angucyclinones. J Org Chem 1997 ;62(8)2350-2356 PMID |
| Uibo R, Uibo O, Reimand K, Peterson P, Krohn K Characterization by molecular cloning an antigen reactive with antireticulin antibodies. Ann N Y Acad Sci 1997 ;815509-11 PMID |
| Spence AM, Graham MM, Muzi M, Freeman SD, Link JM, Grierson JR, O'Sullivan F, Stein D, Abbott GL, Krohn KA Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: studies in rat brain tumor models. J Nucl Med 1997 ;38(4)617-24 PMID |
| Deodhar AA, Bruce MG, Krohn KD, Bennett RM A case of secondary Sjogren's syndrome with a swollen thigh. Ann Rheum Dis 1997 ;56(3)162-4 PMID |
| Peterson P, Uibo R, Peranen J, Krohn K Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APS I) sera; further evidence for independent humoral immunity to P450c17 and P450c21. Clin Exp Immunol 1997 ;107(2)335-40 PMID |
| Arab SF, Krohn K, Lachmund A, Unsicker K, Suter-Crazzolara C The gene encoding bovine brain-derived neurotrophic factor (BDNF). Gene 1997 ;185(1)95-8 PMID |
| Ranki A, Krohn K [Chemokine receptors and HIV infections] Duodecim 1997 ;113(5)361-3 PMID |
| Tahtinen M, Ranki A, Valle SL, Ovod V, Krohn K B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains. Biomed Pharmacother 1997 ;51(10)480-7 PMID |
| Ranki A, Suni J, Blazevic V, Holmstrom P, Mattinen S, Krohn K, Valle SL T-cell recognition of HIV antigens in HIV-seroreverted persons. AIDS 1997 ;11(1)132-3 PMID |
| Link JM, Krohn KA, Clark JC Production of [11C]CH3I by single pass reaction of [11C]CH4 with I2. Nucl Med Biol 1997 ;24(1)93-7 PMID |
| Peterson P, Salmi H, Hyoty H, Miettinen A, Ilonen J, Reijonen H, Knip M, Akerblom HK, Krohn K Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. Clin Immunol Immunopathol 1997 ;82(1)37-42 PMID |
| Vesanen M, Markowitz M, Cao Y, Ho DD, Saksela K Human immunodeficiency virus type-1 mRNA splicing pattern in infected persons is determined by the proportion of newly infected cells. Virology 1997 ;236(1)104-9 PMID |
| Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997 ;387(6629)188-91 PMID |
| Saksela K [HIV infection can be treated] Duodecim 1997 ;113(16)1515, 1517-8 PMID |
| Silvennoinen O Immunodeficiencies and haematological disorders--direct connections to cellular signalling pathways. Ann Med 1997 ;29(6)519-29 PMID |
| Berchtold S, Moriggl R, Gouilleux F, Silvennoinen O, Beisenherz C, Pfitzner E, Wissler M, Stocklin E, Groner B Cytokine receptor-independent, constitutively active variants of STAT5. J Biol Chem 1997 ;272(48)30237-43 PMID |
| Saharinen P, Ekman N, Sarvas K, Parker P, Alitalo K, Silvennoinen O The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. Blood 1997 ;90(11)4341-53 PMID |
| Silvennoinen O, Saharinen P, Paukku K, Takaluoma K, Kovanen P Cytokine receptor signal transduction through Jak tyrosine kinases and Stat transcription factors. APMIS 1997 ;105(7)497-509 PMID |
| Stancato LF, Sakatsume M, David M, Dent P, Dong F, Petricoin EF, Krolewski JJ, Silvennoinen O, Saharinen P, Pierce J, Marshall CJ, Sturgill T, Finbloom DS, Larner AC Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Mol Cell Biol 1997 ;17(7)3833-40 PMID |
| Spelbrink JN, Zwart R, Van Galen MJ, Van den Bogert C Preferential amplification and phenotypic selection in a population of deleted and wild-type mitochondrial DNA in cultured cells. Curr Genet 1997 ;32(2)115-24 PMID |
| Koivisto P, Visakorpi T, Rantala I, Isola J Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer. J Pathol 1997 ;183(1)51-6 PMID |
| Kuukasjarvi T, Tanner M, Pennanen S, Karhu R, Visakorpi T, Isola J Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes Cancer 1997 ;18(2)94-101 PMID |
| Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi OP Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 1997 ;57(2)314-9 PMID |
| Matikainen M, Schleutker J, Visakorpi T, Kallioniemi OP [ Hereditary prostate cancer with gene location] Duodecim 1997 ;113(6)461-2 PMID |
| Palmberg C, Koivisto P, Hyytinen E, Isola J, Visakorpi T, Kallioniemi OP, Tammela T Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade. Eur Urol 1997 ;31(2)216-9 PMID |
| Hyytinen ER, Thalmann GN, Zhau HE, Karhu R, Kallioniemi OP, Chung LW, Visakorpi T Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model. Br J Cancer 1997 ;75(2)190-5 PMID |
Institute of Biomedical Technology
Biokatu 8, 12
33520 Tampere, Finland
Biokatu 8, 12
33520 Tampere, Finland
